Baroreflex Sensitivity Impairment Is Associated With Cardiac Diastolic Dysfunction in Rats
Carregando...
Citações na Scopus
23
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
Autores
MEDEIROS, Alessandra
PIRATELLO, Aline Cristina
BRUM, Patricia Chakur
Citação
JOURNAL OF CARDIAC FAILURE, v.17, n.6, p.519-525, 2011
Resumo
Background: Studies have shown that the autonomic dysfunction accompanied by impaired baroreflex sensitivity was associated with higher mortality. However, the influence of decreased baroreflex sensitivity on cardiac function, especially in diastolic function, is not well understood. This study evaluated the morpho-functional changes associated with baroreflex impairment induced by chronic sinoaortic denervation (SAD). Methods and Results: Animals were divided into sinoaortic denervation (SAD) and control (C) groups. Baroreflex sensitivity was evaluated by tachycardic and bradycardic responses, induced by vasoactive drugs. Cardiac function was studied by echocardiography and by left ventricle (LV) catheterization. LV collagen content and the expression of regulatory proteins involved in intracellular Ca(2+) homeostasis were quantified. Results showed higher LV mass in SAD versus C animals. Furthermore, an increase in deceleration time of E-wave in the SAD versus the C group (2.14 +/- 0.07 ms vs 1.78 +/- 0.03 ms) was observed. LV end-diastolic pressure was increased and the minimum dP/dt was decreased in the SAD versus the C group (12 +/- 1.5 mm Hg vs 5.3 +/- 0.2 mm Hg and 7,422 +/- 201 vs 4,999 +/- 345 mm Hg/s, respectively). SERCA/NCX ratio was lower in SAD than in control rats. The same was verified in SERCA/PLB ratio. Conclusions: The results suggest that baroreflex dysfunction is associated with cardiac diastolic dysfunction independently of the presence of other risk factors. (J Cardiac Fail 2011;17:519-525)
Palavras-chave
Baroreflex, diastolic function, cardiac hypertrophy, intracellular Ca(2+)
Referências
- IRIGOYEN MC, 1995, HYPERTENSION, V26, P1111
- Brum PC, 2006, AN ACAD BRAS CIENC, V78, P485, DOI 10.1590/S0001-37652006000300009
- Martinka P, 2005, AM J PHYSIOL-REG I, V288, pR767, DOI 10.1152/ajpregu.00445.2004
- La Rovere MT, 2009, J AM COLL CARDIOL, V53, P193, DOI 10.1016/j.jacc.2008.09.034
- Montes GS, 1996, CELL BIOL INT, V20, P15, DOI 10.1006/cbir.1996.0004
- Van Vliet BN, 1999, J PHYSIOL-LONDON, V516, P885
- Grassi G, 2010, HYPERTENS RES, V33, P381, DOI 10.1038/hr.2010.26
- Post SR, 1999, ANNU REV PHARMACOL, V39, P343, DOI 10.1146/annurev.pharmtox.39.1.343
- Medeiros A, 2008, J APPL PHYSIOL, V104, P103, DOI 10.1152/japplphysiol.00493.2007
- Mostarda C, 2010, CLIN EXP PHARMACOL P, V37, P447, DOI 10.1111/j.1440-1681.2009.05327.x
- Miao CY, 2006, J HYPERTENS, V24, P1125, DOI 10.1097/01.hjh.0000226203.57818.88
- Grassi G, 2009, HYPERTENSION, V53, P205, DOI 10.1161/HYPERTENSIONAHA.108.121467
- KRIEGER EM, 1964, CIRC RES, V15, P511
- Mostarda C, 2009, AUTON NEUROSCI-BASIC, V145, P11, DOI 10.1016/j.autneu.2008.10.010
- Carr AN, 2002, MOL CELL BIOL, V22, P4124, DOI 10.1128/MCB.22.12.4124-4135.2002
- Moraes-Silva IC, 2010, CLIN EXP PHARMACOL P, V37, pe114, DOI 10.1111/j.1440-1681.2009.05333.x
- Liu AJ, 2007, STROKE, V38, P1916, DOI 10.1161/STROKEAHA.106.480061
- Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010
- Kudo H, 2009, HYPERTENSION, V54, P832, DOI 10.1161/HYPERTENSIONAHA.109.135905
- Borlaug BA, 2006, CIRCULATION, V114, P2138, DOI 10.1161/CIRCULATIONAHA.106.632745
- Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JC125397
- Bai Xufang, 2008, Open Cardiovasc Med J, V2, P9, DOI 10.2174/1874192400802010009
- Biaggioni I, 2007, AM J MED SCI, V334, P61, DOI 10.1097/MAJ.0b013e318065c03b
- Braga LMGD, 2008, J BIOMED SCI, V15, P365, DOI 10.1007/s11373-008-9237-z
- Brum PC, 2002, AM J PHYSIOL-HEART C, V283, pH1838, DOI 10.1152/ajpheart.01063.2001
- La Rovere MT, 1998, LANCET, V351, P478
- NEUMANN J, 1993, AM J PHYSIOL, V265, pH257
- SASAKI S, 1994, AM J HYPERTENS, V7, P453
- Senzaki H, 1999, J AM COLL CARDIOL, V34, P1529, DOI 10.1016/S0735-1097(99)00362-9
- Soares PPDA, 2004, AUTON NEUROSCI-BASIC, V113, P24, DOI 10.1016/j.autneu.2004.05.002
- Stern Javier E., 1994, Biological Signals, V3, P15